Research Archive — Page 78 of 134
-
December 17, 2020
Study reveals distinct genomic landscape for young adults with appendiceal cancer
The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances for this rare disease. -
December 15, 2020
A deeper look at out-of-home care
Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report. -
December 14, 2020
Polymer protection for heart muscle
Vanderbilt researchers demonstrate that the polymer P188 has promise as a therapy to prevent reperfusion injury — the cellular damage that occurs when blood flow returns after an ischemic event like a heart attack. -
December 10, 2020
Model students: improving clinical decision-making
Vanderbilt investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models. -
December 10, 2020
Exploiting viral vulnerabilities
The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections. -
December 10, 2020
Study sheds light on diabetes and COVID interaction
COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients. -
December 10, 2020
Study details early events of inflammatory response
Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.